<DOC>
	<DOCNO>NCT01384409</DOCNO>
	<brief_summary>To evaluate efficacy safety KW-3357 concomitant use heparin use multi-center , non-comparative , open-label method patient diagnose disseminated intravascular coagulation ( DIC ) Japanese Association Acute Medicine-defined DIC criterion .</brief_summary>
	<brief_title>A Phase 3 Clinical Study KW-3357 Patients With DIC</brief_title>
	<detailed_description />
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<criteria>Japanese Association Acute Medicinedefined DIC criterion score &gt; = 4 Antithrombin activity &lt; = 70 % Written informed consent patient guardian Anamnesis complication serious drug allergy Serious liver disorder , fulminant hepatitis decompensated cirrhosis Pregnant , nursing , possibly pregnant woman Possibility promotion bleed concomitant use heparin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>